QC
CMD

Quadrature Capital’s Cantel Medical Corporation CMD Stock Holding History

Quadrature Capital’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,049
Closed -$478K – 1246
2020
Q4 		$478K Buy
+6,049
New +$355K 0.02% 498
2018
Q4 		– Sell
-3,113
Closed -$287K – 765
2018
Q3 		$287K Buy
+3,113
New +$297K 0.02% 463
2016
Q4 		– Sell
-5,900
Closed -$460K – 846
2016
Q3 		$460K Buy
5,900
+2,380
+68% +$173K 0.04% 373
2016
Q2 		$242K Buy
3,520
+271
+8% +$18.7K 0.02% 471
2016
Q1 		$232K Buy
+3,249
New +$204K 0.03% 362

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Quadrature Capital's CMD Position: Q1 2021 in Review

Quadrature Capital sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 6,049 shares — an estimated $478K sold.

Quadrature Capital first reported a position in CMD in Q1 2016 and held it in 5 quarters. The position peaked at $478K in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Quadrature Capital reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Quadrature Capital sold 6,049 Cantel Medical Corporation shares in Q1 2021, an estimated $478K.
  • Quadrature Capital first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 5 quarters.
  • Quadrature Capital's Cantel Medical Corporation position peaked at $478K in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Quadrature Capital's 13F filing for Q1 2021, filed 17 May 2021.